New Jersey drug testing laws for employers: pre-employment testing rules (2026)

New Jersey has no general statute that limits private-employer drug testing, and its cannabis law expressly allows a drug test as part of pre-employment screening. What it restricts is the decision: under N.J.S.A. 24:6I-52, an employer may not refuse to hire anyone because they do or do not use cannabis, and a drug test must pair an objective test with a physical evaluation of impairment. The Cannabis Regulatory Commission says a metabolite-positive result alone cannot support an adverse employment action, and medical cannabis patients have written-notice and retest rights, as of October 2026.

New Jersey drug testing rules at a glance

Does New Jersey have a drug testing law for employers?

New Jersey has no statute like Vermont's or Minnesota's that sets general testing procedures for every drug. The rules that matter for hiring sit in the cannabis statutes: the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (P.L.2021, c.16, approved February 22, 2021), and the Jake Honig Compassionate Use Medical Cannabis Act as amended in 2019. Section 48 of the 2021 act took effect immediately but, under the act's effective-date section, became operative only once the commission adopted its initial rules.

The commission's workplace and DUI laws page sums up the balance: "While general cannabis use cannot be a determining factor for hiring or firing someone, employers do have the right to maintain a drug and alcohol-free work environment."

Can New Jersey employers test applicants for cannabis?

Yes, but the result is hard to use on its own. Section 48a(1) of the 2021 act says:

• "No employer shall refuse to hire or employ any person" or take adverse action "because that person does or does not smoke, vape, aerosolize or otherwise use cannabis items."
• An employee "shall not be subject to any adverse action by an employer solely due to the presence of cannabinoid metabolites" from conduct the act permits.
• A drug test "may also be done randomly by the employer, or as part of a pre-employment screening, or regular screening of current employees to determine use during an employee's prescribed work hours."
• "The drug test shall include scientifically reliable objective testing methods and procedures, such as testing of blood, urine, or saliva, and a physical evaluation in order to determine an employee's state of impairment."

The protection follows the act's scope: it covers cannabis use the act permits, which means adults 21 and older.

The Workplace Impairment Recognition Expert

Section 48a(2) directs the commission to set standards for a Workplace Impairment Recognition Expert (WIRE) certification, held by employees or contractors trained to detect impairment from cannabis or other substances. As of October 2026, the commission's workplace page still points employers to its September 9, 2022 interim guidance, which it said would serve "until the NJ-CRC formulates and approves standards for WIRE certifications." The guidance says:

• a test "that indicates the presence of cannabinoid metabolites in the employee's bodily fluid alone is insufficient to support an adverse employment action";
• such a test "combined with evidence-based documentation of physical signs or other evidence of impairment during an employee's prescribed work hours may be sufficient";
• employers may designate an interim staff member, who may be a third-party contractor, to help with impairment determinations, and use a uniform Reasonable Suspicion Observation Report signed off by a supervisor and the designated person or a second supervisor; and
• a cognitive impairment test or an ocular scan may count as evidence of impairment.

The guidance is written around employees and work hours. An applicant has no work hours yet, so a metabolite-only pre-employment result rarely comes with the impairment evidence the guidance describes. One cautious option for roles outside the federal exceptions is to leave cannabis off the pre-employment panel and rely on reasonable suspicion testing after hire. Our drug testing laws guide walks through a New Jersey example with two candidates and one policy.

What rights do medical cannabis patients have?

N.J.S.A. 24:6I-6.1, added in 2019, applies to job applicants as well as employees:

1. No adverse employment action "based solely on the employee's status as a registrant with the commission."
2. If an employer "has a drug testing policy and an employee or job applicant tests positive for cannabis," it must offer a chance to present a legitimate medical explanation and give written notice of that right.
3. Within three working days of the notice, the person may submit information explaining the result, including an authorization for medical cannabis or proof of registration, or request a confirmatory retest of the original sample at their own expense.

The section does not stop an employer from acting on possession or use of intoxicating substances during work hours, or require it to violate federal law or lose a federal contract, federal funding or a federal licensing-related benefit.

Which federal rules still apply in New Jersey?

• DOT testing. Commercial drivers need a verified negative result before first performing safety-sensitive functions (49 CFR § 382.301). Under 49 CFR § 40.151(e), a Medical Review Officer may not verify a positive as negative because a physician recommended marijuana under a state law, so a New Jersey registration does not change a DOT result.
• Federal contractors. Section 48b(1)(b) lets an employer subject to a federal contract revise its employee prohibitions to match federal law if the state provisions cause a provable adverse impact, and the commission's guidance notes such employers may follow federally required protocols. The Drug-Free Workplace Act, 41 U.S.C. § 8102, requires a policy statement, an awareness program and conviction reporting; its listed requirements do not include testing.

What should staffing agencies placing workers in New Jersey do?

1. Decide who orders the test. The agency that makes the offer is the employer acting on the result, so its policy, not only the client's, must meet section 48.
2. Separate federal roles. Mark DOT-regulated and federal contract orders before posting; those follow federal rules.
3. Give patients their notice. If any test includes cannabis, build the written right-to-explain notice and the three-working-day window into the process.
4. Document, do not infer. A positive metabolite screen with nothing else in the file is weak support for withdrawing an offer.

The rest of New Jersey's hiring rules, including the Opportunity to Compete Act's limits on criminal history questions, are in our New Jersey hiring checklist and New Jersey ban-the-box guide.

Checklist: before you drug test an applicant in New Jersey

1. List the jobs you test, and flag DOT-regulated and federal contract jobs separately.
2. For other jobs, decide whether cannabis belongs on the pre-employment panel at all.
3. If it does, pair the test with a documented physical evaluation by a trained person, following the commission's interim guidance.
4. Send written notice of the right to explain to any applicant who tests positive for cannabis, and allow three working days.
5. Route results through a Medical Review Officer and keep them out of interview notes.
6. Put it in writing with the drug testing policy template, and compare New York's rules if you hire on both sides of the Hudson.